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Background: Stress-induced cardiomyopathy (sCMP) is characterized by transient wall-motion abnormalities
involving the left ventricular apex and mid-ventricle that are precipitated by emotional or physical stress. As the
heart and kidney influence each other’s function through bidirectional pathways, sCMP can induce renal
dysfunction or be induced by renal dysfunction. This study reviewed the clinical characteristics and outcomes of
patients with confirmed sCMP associated with renal dysfunction.
Methods: We conducted a retrospective analysis of the medical records of all patients from our institution who
were diagnosed with sCMP from March 2010 to April 2012. Each patient’s demographic characteristics, presenting
symptoms, triggering events, electrocardiographic characteristics, laboratory data, echocardiographic study findings,
cardiac catheterization data, and outcomes were reviewed.
Results: Among 30 patients who were diagnosed with sCMP, 7 patients had associated renal dysfunction. Three
patients were on maintenance hemodialysis (HD) and 4 patients had acute kidney injury (AKI). Their mean ejection
fraction was 35.2% at initial echocardiography, and 57.2% at follow-up echocardiography. Pericardial effusion was
detected in all HD patients initially; these patients were treated with intensive HD for suspected under-dialysis
status. In patients with AKI, the mean peak serum creatinine was 4.17 mg/dL. Two patients were treated with
continuous renal replacement therapy. One patient required maintenance HD, and 1 patient died. Two patients had
full renal recovery to their baseline renal function at 7 and 14 days.
Conclusions: Patients with renal dysfunction including those with AKI and those undergoing HD can develop
sCMP, renal function must be closely monitored in patients with sCMP. Additionally, it should be considered that
patients on HD who develop sCMP may be under-dialyzed.
Keywords: Stress cardiomyopathy, Acute kidney injury, HemodialysisBackground
Stress-induced cardiomyopathy (sCMP)-also known as
takotsubo cardiomyopathy, broken heart syndrome, or
transient left apical ballooning syndrome-usually presents
as transient left ventricular dysfunction. This syndrome
mimics an acute coronary syndrome, electrocardiograms
(ECG) often reveal ST elevations, T wave inversion, and* Correspondence: sey-0220@hanmail.net
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reproduction in any medium, provided the orQ waves. Cardiac enzymes are also elevated but the cor-
onary arteries are essentially normal. To date, there
have been more than 1000 reports published on sCMP.
It is estimated that sCMP accounts for 2% of all
suspected acute coronary syndromes with 90% of the
cases being in postmenopausal women. In all, 39%-80%
of patients provide a history of a recent severe emo-
tional or physical stressor [1,2]. Classic takotsubo car-
diomyopathy is characterized by transient hypokinesia
of the apical portion of the left ventricle with compen-
satory hyperkinesias of the basal walls, resulting in ap-
ical ballooning. Recently, reverse or inverted takotsubod. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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hyperdynamic apex and akinesia of the base of left ven-
tricular wall [3,4]. It is generally resolved within days to
weeks after initial presentation, and the overall progno-
sis seems to be favorable, although isolated cases of
death have been reported.
Cardiorenal syndrome (CRS) is a disorder of the heart
and kidney, whereby acute or long-term dysfunction in
one of these organs may induce acute or long-term dys-
function of the other. Changes in the renin-angiotensin
-aldosterone system, the sympathetic nervous system, an
imbalance between nitric oxide and reactive oxygen spe-
cies, and inflammation are the cardiorenal connectors in
the development of CRS [5]. Similar to that observed in
CRS, sCMP can induce renal dysfunction or be induced
by renal dysfunction. However, there has been only 1
case report of sCMP with acute kidney injury (AKI) [6].
In this report, we reviewed a case series of 7 patients
with confirmed sCMP associated with renal dysfunction
including prevalent hemodialysis (HD) or acute kidney
injury.
Methods
We conducted a retrospective analysis of the medical
records of all patients from our institution who were diag-
nosed with sCMP from March 2010 to April 2012. Pa-
tients who met the following criteria of sCMP were
included: (1) development of typical takotsubo or inverted
takotsubo on echocardiography after emotional or phys-
ical stress; (2) no evidence of obstructive epicardial coron-
ary artery disease on coronary angiography (CAG); for
those patients who could not undergo CAG, follow-up
echocardiography showing improvement of left ventricu-
lar function was used to demonstrate the absence of
coronary artery obstruction; (3) new ECG abnormalities,
including ST-segment elevation, T-wave inversion, or
arrhythmia and elevation in troponin I. We identified 30
patients with sCMP. Of these, 7 patients had associated
renal dysfunction. Three patients were on maintenance
HD with anuric state and 4 patients had AKI. AKI was di-
agnosed according to the RIFLE criteria, which can be
used to classify patients with renal dysfunction according
to the degree of impairment into “Risk,” “Injury,” “Failure,”
“Sustained loss,” and “End-stage renal disease” categories
[7]. Each patient’s demographic characteristics, presenting
symptoms, triggering events, ECG characteristics, la-
boratory data, echocardiographic study findings, cardiac
catheterization data, and outcomes were reviewed.
Three patients (42.8%) were women and the mean age
was 65 years (range, 53 to 77 years). The protocol was
approved by the institutional review board of Pusan
National University Hospital (E-2012059). Informed
consent was exempted by the board because of the
retrospective nature of the study.Results
Clinical characteristics and laboratory findings of the 4
patients with AKI and sCMP are listed in Tables 1 and
2. Three patients were men and the age range was 53 to
77 years. Two patients had diabetes mellitus and atrial
fibrillation, and 1 patient had anti-neutrophil cytoplas-
mic autoantibody (ANCA)-associated rapidly progressive
glomerulonephritis (RPGN). The fourth was a patient
with pyriform sinus cancer who underwent adjuvant
chemotherapy. On admission, only 1 patient presented
with chest pain; the remaining 3 patients presented with
dyspnea. The triggering event in all 4 patients was phys-
ical stress, which consisted of pneumonia and hypox-
emia in 2 patients, infectious colitis in 1 patient, and
RPGN in 1 patient. The ECG findings on admission
were diffuse T-wave inversion in leads V1 to V6 in 2 pa-
tients and ST-segment elevation in the precordial leads
in 1 patient. The second patient had only QTc prolonga-
tion (QTc = 501 ms). All patients indicated a small in-
crease in cardiac enzyme levels. On Echocardiography at
presentation, 3 patients showed the typical takotsubo
pattern with left ventricular dysfunction (Figure 1) and
the other patient had an inverted takotsubo pattern with
left ventricular dysfunction. The mean ejection fraction
(EF) was 36.2% (range, 30-48%). Three patients were
evaluated with follow-up echocardiography and showed
improvement of left ventricular function within a few
weeks (range, 2-4 weeks). On follow-up echocardiog-
raphy of 3 patients, the mean EF was 59.0% (range, 52-
68%), and no regional wall motion abnormalities were
noted. The second patient underwent CAG and indi-
cated no evidence of obstructive epicardial coronary ar-
tery disease (Figure 2).
In all 4 patients, the mean baseline serum creatinine was
1.02 mg/dL and the mean serum creatinine at the time of
initial echocardiography was 3.0 mg/dL. The first patient’s
peak serum creatinine level was 3.76 mg/dL. As this pa-
tient had unstable blood pressure with inotropic agent use
and decreased urine volume (<400 mL/day), continuous
renal replacement therapy (CRRT) was initiated, using the
mode of continuous venovenous hemodiafiltration. She
was treated with CRRT for 96 hours. After the CRRT was
discontinued, she entered the polyuric stage and her renal
function returned to baseline within approximately 7 days
after diagnosed AKI. She exhibited normal renal function
and no recurrence of sCMP at the last examination
performed in the nephrology department. Therefore, the
degree of renal impairment was “Failure,” according to the
RIFLE criteria. The second patient had a maximum cre-
atinine level of 3.45 mg/dL with decreased urine volume
(urine volume <300 mL/day) and unstable blood pressure
with inotropic agent use; therefore, CRRT was initiated.
However, he died during the hospital period. His death
was attributed to recurrent ventricular tachycardia. The












1 DM, HT, AF Chest pain Infectious colitis Failure CRRT Recovery to baseline renal function and
no recur of sCMP
2 DM, AF Dyspnea Pneumonia — CRRT In-hospital death from recurrent VT
3 ANCA-RPGN Dyspnea ANCA-RPGN ESRD Conventional HD Maintenance HD and no recur of sCMP
4 Pyriform sinus cancer Dyspnea Peumonia Injury No Recovery to baseline renal function and
no recur of sCMP
DM diabetes mellitus, HT hypertension, AF atrial fibrillation, ANCA-RPGN anti-neutrophil cytoplasmic autoantibody-associated rapidly progressive
glomerulonephritis, ESRD end-stage renal disease, CRRT continuous renal replacement therapy, HD hemodialysis, sCMP stress-induced cardiomyopathy, VT
ventricular tachycardia.
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and received steroid pulse therapy and cyclophosphamide
therapy along with conventional hemodialysis. Despite the
immunosuppressive regimen, his renal function did not
improve, and therefore, maintenance hemodialysis was ini-
tiated. He did not exhibit any recurrence of sCMP at his
last follow-up examination. The degree of renal impair-
ment was “End-stage renal disease” according to the RI-
FLE criteria. In the fourth patient, the serum creatinine
level reached to 2.19 mg/dL and then decreased to base-
line levels after 14 days, with no recurrence of sCMP. The
degree of renal impairment according to the RIFLE criteria
was “Injury.”
Clinical characteristics and laboratory findings of the 3
patients under prevalent hemodialysis who developed
sCMP are listed in Tables 3 and 4. Two patients were
women and the age range was 54 to 68 years. All 3 pa-
tients had diabetes mellitus and hypertension, and 1 pa-
tient had atrial fibrillation and bronchial asthma. All 3
patients were under prevalent hemodialysis with anuric
state; their weekly Kt/V values were 3.0, 2.58, and 3.52,
respectively. At admission, these 3 patients presented
with dyspnea. The triggering event for each of these
patients was physical stress, which included pneumonia
and hypoxemia in 2 patients and infectious colitis in 1
patient. The ECG findings at admission were diffuse T-
wave inversion in leads V1 to V6 in 1 patient, ST-
segment elevation in the precordial leads in 1 patient,Table 2 ECG characteristics, laboratory data, echocardiograph































ECG electrocardiography, EF ejection fraction, NA not available, hs-CRP high sensitivand QTc prolongation (QTc = 504 ms) in 1 patient. Two
patients indicated a small increase in cardiac enzyme
levels. On echocardiography at presentation, all patients
indicated a typical takotsubo pattern with pericardial ef-
fusion, and the mean EF was 34.0% (range, 30-37%).
Two patients were evaluated with follow-up echocardi-
ography and showed improvement of left ventricular
function with a mean EF of 55% within a few weeks
(range, 1-2 weeks). The other patient underwent CAG
and had no evidence of obstructive epicardial coronary
artery disease. Because pericardial effusion was detected
in all patients and 2 of them had uremic encephalopathy,
these 3 patients were treated with intensive hemodialysis
for suspected under-dialysis status. All the patients
were treated with conventional hemodialysis and did
not exhibit any complications or recurrence of sCMP
during the last examination performed in the nephrol-
ogy department.
Discussion and conclusions
The cases described in this study illustrate that sCMP
can occur in patients with renal dysfunction, including
end-stage renal disease (ESRD) or AKI. Although sCMP
was initially described in Japanese patients, there have
been several cases reported in other parts of the world.
It is characterized by transient hypokinesia of the apical
portion of the left ventricle with compensatory hyperkin-
















57 % 12.26 1.0 3.76 1.03 7
NA 9.61 0.73 3.45 — —
52% 2.13 1.44 7.29 — —
68% 19.1 0.9 2.19 1.02 14
e C-reactive protein, SCr serum creatinine.
Figure 1 Left ventriculogram in diastole (Left) and systole (Right) of stress-induced cardiomyopathy showing apical ballooning of the
left ventricle.
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trap or “takotsubo.” This syndrome mimics an acute cor-
onary syndrome as ECG often reveals ST-segment eleva-
tions or T-wave inversions in the precordial leads. The
levels of cardiac enzymes are elevated, but angiography
shows normal coronary arteries or only minor disease
inconsistent with the ECG changes. In previous studies,
39%-80% of patients provide a history of a recent severe
emotional or physical stressor [1,2]. Interestingly, the
stressor in all of our patients was physical in nature. The
exact mechanism and pathophysiology of sCMP is un-
known. There have been a number of theories suggested
so far, with catecholamine-induced cardiotoxicity being
the most widely supported hypothesis [8]. Plasma cat-
echolamine concentrations at the time of onset were
increased in patients with sCMP when compared to
patients with myocardial infarction [9]. Exogenous ad-
ministration of catecholamines and pheochromocytoma
have been reported to cause typical features of sCMP
adding more evidence to this theory [10,11]. During
stressful conditions, the sympathetic nervous system is
activated, and this may influence myocardial contraction.
In addition, a different distribution of sympathetic nervesFigure 2 Angiogram showing normal coronary arteries.in the myocardium may also be associated with the pecu-
liar wall-motion abnormality. It has been known that
sympathetic nervous system hyperactivity is observed in
patients with ESRD. Activation of the sympathetic ner-
vous system, assessed using plasma norepinephrine levels,
is observed in patients with ESRD treated with HD and in
those with early ESRD without HD treatment; the plasma
norepinephrine levels in these patients is significantly
higher than those in blood pressure-matched and body
mass index-matched hypertensive patients or healthy
normotensive subjects [12]. Inflammation and oxidative
stress play an important role in the pathogenesis of micro-
vascular dysfunction [13,14]. Recent study found raised C-
reactive protein and leucocyte levels in correlation with
increased norepinephrine concentration in sCMP patients
[15]. It has been demonstrated that vitamin E levels,
known to act as a chain-breaking antioxidant that pre-
vents the propagation of free radical reactions, are lower
in dialysis patients compared to controls, indicating that
there is a significant level of oxidative stress in chronic
renal patients [16]. In addition, after dialysis, because of
the removal of the antioxidants, an imbalance between
oxidants and antioxidants occurs, these instability in the
Table 3 Clinical characteristics of patients under prevalent hemodialysis with stress-induced cardiomyopathy
Patient No. Underlying disease Weekly Kt/V Presenting symptom Triggering event Renal replacement therapy Outcomes
5 ESRD, DM, HT 3.0 Dyspnea Pneumonia Intensive HD No recur of sCMP
6 ESRD, DM, HT 2.58 Dyspnea Infectious colitis Intensive HD No recur of sCMP
7 ESRD, DM, HT, AF, Asthma 3.52 Dyspnea Pneumonia Intensive HD No recur of sCMP
ESRD end-stage renal disease, DM diabetes mellitus, HT hypertension, AF atrial fibrillation, HD hemodialysis, sCMP stress-induced cardiomyopathy.
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cause of cellular oxidative damage. Thus, it can be pre-
sumed that, given the conditions of sympathetic nervous
hyperactivity and imbalance between oxidants and antiox-
idants in ESRD patients, triggering of stress might induce
sCMP more frequently in these patients than in healthy
subjects. Further, all 3 of our patients under maintenance
hemodialysis were suspected to have an under-dialysis sta-
tus because of pericardial effusion and uremic encephal-
opathy. Therefore, we can presume that the under-dialysis
status itself may be a triggering factor for sCMP as a stres-
sor, although further studies are needed to confirm these
associations.
Various patterns of sCMP have been recently recog-
nized. In the inverted takotusbo pattern, which is a vari-
ant of sCMP, the left ventricular wall exhibits akinesia of
the base and hyperdynamic apex [17,18]. This pattern
has been known to present at an earlier age compared
with other types of sCMP and has been triggered by
emotional or physical stress in all patients [18]. This dif-
ference in presentation has been attributed to differences
in the sympathetic innervations of the heart with the
abundance of adrenoreceptors at the apex compared with
the base. One of our patients had an inverted takotusbo
pattern in initial echocardiography. As mentioned earlier,
the most common finding on the admission ECG was ST-
segment elevation. In recent study, the classic ECG fea-
tures included ST elevation (56%), T wave inversion (39%)
and pathological Q waves (32%) [19]. Arrhythmia has been
reported in 43.5% of cases with ventricular fibrillation, tor-
sade des pointes, ventricular tachycardia and prolonged
QTc being the most common and life-threatening arrhyth-
mias occurring in up to 5.7%. New left and right bundle-
branch block on the presenting ECG has been reported.Table 4 ECG characteristics, laboratory data, echocardiograph
prevalent hemodialysis with stress-induced cardiomyopathy
Patient No. ECG abnormality Echocardiographic abnormality
at presentation
5 ST-segment elevation Typical takotsubo, Pericardial effusion,
EF = 35%
6 T -wave inversion Typical takotsubo, Pericardial effusion,
EF = 37%
7 QTc prolongation Typical takotsubo, Pericardial effusion,
EF = 30%
ECG electrocardiography, EF ejection fraction, NA not available, hs-CRP high sensitivThe QTc interval on the presenting ECG ranged from a
mean of 450 ms to 501 ms [8]. One of our patients had
prolonged QTc interval (501 ms), and he died because of
recurrent ventricular tachycardia.
Recently, as the clinical spectrum of sCMP became
broader and the disease entity was better understood, it
was suggested that it is impractical to routinely perform
invasive coronary angiography for definitive diagnosis of
sCMP. In fact, current criteria for confirming sCMP
include invasive coronary angiography, to exclude the pos-
sibility of obstructive coronary artery disease or acute
plaque rupture. A recent study demonstrated that a com-
bination of typical LV morphologic change of sCMP and
noninvasive demonstration of the absence of significant
plaque rupture can be possible alternative diagnostic cri-
teria [20]. However, these modified criteria require further
evaluation. One of the patients in the present study died
during hospitalization; the death was attributed to recur-
rent ventricular tachycardia. The in-hospital mortality due
to sCMP ranges from 0 to 8%. In view of the associated
mortality, the overall outcome is better than that of pa-
tients with myocardial infarction. Recurrence of this syn-
drome is rare and infrequent. In the largest series so far,
which consisted of 88 patients, a recurrence rate of 2.7%
was reported [21]. In our patients, there has been no re-
currence after a mean duration of 11 months.
Cardiac diseases are independently associated with de-
terioration in kidney function and progression of existing
kidney diseases [22]. Conversely, both decrease in glom-
erular filtration rate and proteinuria are independent risk
factors for the development of cardiovascular disease [23].
CRS is a disorder of the heart and kidney, whereby acute
or long-term dysfunction in 1 of these organs may induce





EF at follow-up hs-CRP (mg/dL)
11.61 NA 51% 7.13
4.73 Normal NA 11.84
0.28 NA 58% 17.42
e C-reactive protein.
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diuresis, natriuresis, peripheral tissue perfusion and oxy-
genation. Recently, a new classification of CRS has been
developed to reflect the likely primary and secondary
pathology and time-frame [24]. Type 1 CRS consists of an
abrupt worsening of cardiac function leading to AKI.
Proposed pathophysiologic mechanisms include reduced
transglomerular pressure, elevated renal interstitial pres-
sure, myogenic and neural reflexes, activation of sympa-
thetic nervous and renin-angiotensin-aldosterone systems,
non-osmotic release of arginine vasopressin, local produc-
tion of endothelin, and enhanced proinflammatory path-
ways. Type 2 CRS comprises chronic abnormalities in
cardiac function causing progressive chronic kidney dis-
ease. Accelerated renal cell apoptosis and replacement fi-
brosis is considered to be the dominant mechanism. Type
3 CRS reflects an abrupt worsening of renal function caus-
ing acute cardiac dysfunction. This syndrome is precipi-
tated by salt and water overload, acute uremic myocyte
dysfunction, and neurohormonal dysregulation. Type 4
CRS comprises a state of chronic kidney disease that con-
tributes to a decline in cardiac function. Cardiac myocyte
dysfunction and fibrosis is believed to be the predominant
pathophysiologic mechanism. Type 5 CRS reflects a sys-
temic condition such as sepsis causing both cardiac and
renal dysfunction. In this type, the predominant patho-
physiological disturbance is microcirculatory dysfunction
as a result of acutely abnormal immune cell signaling, cat-
echolamine cellular toxicity, and enzymatic activation
which result in simultaneous organ injury often extending
beyond both the heart and the kidneys. The use of this
classification can help physicians characterize groups of
patients and provides the rationale for specific manage-
ment strategies.
It could be presumed that sCMP and CRS share the
comparable mechanism regarding the sympathetic ner-
vous system activation, inflammation and oxidative stress
in the pathogenesis of microvascular dysfunction. In our
patients, 4 had AKI (injury, failure, and ESRD in 1 each)
associated with sCMP. Because the serum creatinine level
was already increased at the time that sCMP was diag-
nosed, we could not appropriately classify the patients
according to the CRS classification; instead, we divided
them into acute CRS (type 1 or type 3) depending on the
clinical course or CRS type 5 regarding the sepsis due to
infectious triggering factors.
Two (50%) of the patients with AKI were treated with
CRRT to manage the congestive symptoms and correct
the abnormalities in electrolyte levels and acid–base status,
accompanying hemodynamic instability. In fact, it has been
known that the coexistence of heart and kidney failure in
the same subject is associated with an extremely bad prog-
nosis [25]. In patients with acute heart failure, an acute in-
crease in serum creatinine level of >0.3 mg/dL is associatedwith longer hospitalization time, increased mortality, and
more frequent re-admissions [26]. Although diuretics have
been the mainstay of treatment, they are often unsuccessful
in reversing the vicious cycle of volume overload, worsen-
ing cardiac function, and azotemia. Renal replacement
therapy (RRT) in the form of isolated or continuous ultra-
filtration, with or without a component of solute clearance
(hemofiltration or hemodialysis), has been increasingly uti-
lized as a therapeutic tool in this setting. A previous study
examined the isolated ultrafiltration strategy in 100 pa-
tients with hypervolemic congestive heart failure compared
with the intravenous diuretics strategy adopted in 100
patients. It demonstrated greater weight loss, decreased
need for vasoactive drugs, and fewer rehospitalizations and
emergency department visit in the ultrafiltration group, but
no difference in mortality [27]. Although the clinical neces-
sity of RRT in cases of life-threatening hyperkalemia or
acidemia with AKI is clear, the adjunctive role of RRT
(hemofiltration or hemodialysis) in the treatment of acute
decompensated heart failure is not obvious. A previous
study suggested that because severe hypocalcemia is a
potential cause of reversible heart failure and acute or
acute on chronic renal dysfunction is often hypocalcemic,
correction of hypocalcaemia via continuous venovenous
hemofiltration might improve cardiac function in acute de-
compensated heart failure [28]. However, further research
examining the use of RRT in CRS is necessary.
Our current study has some limitations. First, the
number of patients is small. Second, significant numbers
of patients did not meet the current definition of classic
sCMP. As it was not possible to perform invasive coron-
ary angiography in 5 patients, we demonstrated the ab-
sence of coronary artery obstruction showing recovery
of wall motion abnormality and improvement of left
ventricular function to perform follow-up echocardiog-
raphy. Third, we could not present the exact relevance
of sCMP and CRS. Further investigation is necessary to
overcome these limitations.
In conclusion, these cases showed that concomitant
sCMP can occur in patients with renal dysfunction in-
cluding ESRD or AKI, especially associated with CRS.
Therefore, the renal function of any patient with sCMP
should be closely monitored to facilitate the early diag-
nosis of AKI. ESRD patient who develops sCMP could
be considered to be under-dialyzed, but further studies
are needed to confirm this.
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